"We are pleased to announce the release of our proprietary imaging sciences application which will further enhance the drug development continuum by offering sponsors advanced technologies and integrated data management processes, all designed to ensure the timely execution on project timelines", said CoreLab Partners’ president and chief executive officer, Dr Mike Woehler. "Through substantial investment and our close strategic relationship with a global pioneer in the development of complex scientific technologies, we have created a state-of-the-art imaging sciences tool that will serve as a platform for a series of enabling applications. This will lead to continued expansion of our overall capabilities and imaging modalities, to include new therapeutic areas, over the next several months", added Woehler.
The ImagEngine® system is a unique software program which will be utilised exclusively by CoreLab Partners’ board-certified Radiologists to calibrate, read, annotate and review digitised medical images. This exciting advancement is an integral component of a technological suite of solutions to enhance productivity, improve quality and accelerate timelines.
Various elements of the staged roll-outs will include: